Alpha Teknova (TKNO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $7.60, -2.44% vs the prior close of $7.79.
- Volume 353.10K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TKNO dips 2.4% to $7.60, 4 down days in a row. Closed at $7.60, -2.44% vs the prior close of $7.79. Day range $7.32–$7.84, opened at $7.56.
TKNO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TKNO dips 2.4% to $7.60, 4 down days in a row
- Closed at $7.60, -2.44% vs the prior close of $7.79. Day range $7.32–$7.84, opened at $7.56.
- Volume was 353.10K shares, 1.3x its 50-day average of 274.51K.
- Price is -1.5% vs its 50-day average ($7.72) and +61.0% vs its 200-day average ($4.72).
- 52-week range $1.91–$9.48; today's close sits at 75% of that range, 19.8% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — TKNO slides 5.2% to $7.79, 3 down days in a row
- Closed at $7.79, -5.23% vs the prior close of $8.22. Day range $7.78–$8.29, opened at $8.15.
- Volume was 236.40K shares, 0.9x its 50-day average of 272.94K.
- Price is +1.4% vs its 50-day average ($7.68) and +65.6% vs its 200-day average ($4.70).
- 52-week range $1.91–$9.48; today's close sits at 78% of that range, 17.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — TKNO slides 5.5% to $8.22
- Closed at $8.22, -5.52% vs the prior close of $8.70. Day range $8.22–$8.76, opened at $8.69.
- Volume was 232.10K shares, 0.9x its 50-day average of 270.85K.
- Price is +7.7% vs its 50-day average ($7.63) and +75.5% vs its 200-day average ($4.68).
- 52-week range $1.91–$9.48; today's close sits at 83% of that range, 13.3% below the 52-week high.
Oct 12, 2026 — TKNO dips 1.6% to $8.70
- Closed at $8.70, -1.58% vs the prior close of $8.84. Day range $8.47–$8.90, opened at $8.85.
- Volume was 159.20K shares, 0.6x its 50-day average of 268.61K — lighter than usual.
- Price is +14.8% vs its 50-day average ($7.58) and +86.5% vs its 200-day average ($4.66).
- 52-week range $1.91–$9.48; today's close sits at 90% of that range, 8.2% below the 52-week high.
Oct 9, 2026 — TKNO jumps 4.7% to $8.84
- Closed at $8.84, +4.74% vs the prior close of $8.44. Day range $8.46–$9.04, opened at $8.48.
- Volume was 195.30K shares, 0.7x its 50-day average of 266.29K.
- Price is +17.8% vs its 50-day average ($7.50) and +90.5% vs its 200-day average ($4.64).
- 52-week range $1.91–$9.48; today's close sits at 92% of that range, 6.8% below the 52-week high.
Oct 8, 2026 — TKNO slides 3.1% to $8.44, 3 down days in a row
- Closed at $8.44, -3.10% vs the prior close of $8.71. Day range $8.38–$8.64, opened at $8.64.
- Volume was 253.00K shares, 1.0x its 50-day average of 262.77K.
- Price is +13.7% vs its 50-day average ($7.43) and +82.7% vs its 200-day average ($4.62).
- 52-week range $1.91–$9.48; today's close sits at 86% of that range, 11.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — TKNO dips 0.5% to $8.71
- Closed at $8.71, -0.46% vs the prior close of $8.75. Day range $8.34–$8.88, opened at $8.62.
- Volume was 267.70K shares, 1.0x its 50-day average of 259.07K.
- Price is +18.4% vs its 50-day average ($7.36) and +89.3% vs its 200-day average ($4.60).
- 52-week range $1.91–$9.48; today's close sits at 90% of that range, 8.1% below the 52-week high.
Oct 6, 2026 — TKNO dips 2.8% to $8.75
- Closed at $8.75, -2.78% vs the prior close of $9.00. Day range $8.61–$9.41, opened at $9.06.
- Volume was 377.00K shares, 1.5x its 50-day average of 253.93K.
- Price is +20.1% vs its 50-day average ($7.28) and +91.1% vs its 200-day average ($4.58).
- 52-week range $1.91–$9.48; today's close sits at 90% of that range, 7.7% below the 52-week high.
Oct 5, 2026 — TKNO ends flat (+0.1%) to $9.00 on 1.9x normal volume
- Closed at $9.00, +0.11% vs the prior close of $8.99. Day range $8.68–$9.19, opened at $8.91.
- Volume was 480.10K shares, 1.9x its 50-day average of 246.92K — unusually heavy trading.
- Price is +24.9% vs its 50-day average ($7.21) and +97.4% vs its 200-day average ($4.56).
- 52-week range $1.91–$9.48; today's close sits at 94% of that range, 5.1% below the 52-week high.
Oct 2, 2026 — TKNO rises 1.5% to $8.99
- Closed at $8.99, +1.47% vs the prior close of $8.86. Day range $8.80–$9.04, opened at $8.96.
- Volume was 248.80K shares, 1.0x its 50-day average of 243.95K.
- Price is +26.2% vs its 50-day average ($7.13) and +98.1% vs its 200-day average ($4.54).
- 52-week range $1.91–$9.48; today's close sits at 94% of that range, 5.2% below the 52-week high.
TKNO latest news & SEC filings
Every SEC filing by or about TKNO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $12.19M (prior year $10.29M) (+18.5% vs Jun 30, 2025)
- Net income: -$3.17M (prior year -$3.57M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.06 (prior year -$0.07) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 16, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade TKNO
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.78% (largest 7.1%).
- Liquidity: about 323.44K shares (≈$2.46M) trade per day on average.
- 52-week position: $7.60 vs a range of $1.91–$9.48 (75% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 2 open-market buys, 0 sales; latest: Stephen Gunstream bought 26,000 shares on Mar 6, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 5, 2026; 8-K Jun 1, 2026.
- Share count: 53.69M shares outstanding (Aug 5, 2026), +0.3% vs a year earlier.
- Listing: Nasdaq · industry: In Vitro & In Vivo Diagnostic Substances.
TKNO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 7.56 | 7.84 | 7.32 | 7.60 | 353.10K |
| Oct 14, 2026 | 8.15 | 8.29 | 7.78 | 7.79 | 236.40K |
| Oct 13, 2026 | 8.69 | 8.76 | 8.22 | 8.22 | 232.10K |
| Oct 12, 2026 | 8.85 | 8.90 | 8.47 | 8.70 | 159.20K |
| Oct 9, 2026 | 8.48 | 9.04 | 8.46 | 8.84 | 195.30K |
| Oct 8, 2026 | 8.64 | 8.64 | 8.38 | 8.44 | 253.00K |
| Oct 7, 2026 | 8.62 | 8.88 | 8.34 | 8.71 | 267.70K |
| Oct 6, 2026 | 9.06 | 9.41 | 8.61 | 8.75 | 377.00K |
| Oct 5, 2026 | 8.91 | 9.19 | 8.68 | 9.00 | 480.10K |
| Oct 2, 2026 | 8.96 | 9.04 | 8.80 | 8.99 | 248.80K |
| Oct 1, 2026 | 8.89 | 9.11 | 8.75 | 8.86 | 344.30K |
| Sep 30, 2026 | 9.10 | 9.20 | 8.78 | 8.90 | 288.00K |
| Sep 29, 2026 | 9.21 | 9.31 | 8.86 | 9.08 | 349.70K |
| Sep 28, 2026 | 9.20 | 9.43 | 8.95 | 9.20 | 222.50K |
| Sep 25, 2026 | 9.38 | 9.48 | 9.13 | 9.33 | 291.80K |
| Sep 24, 2026 | 8.82 | 9.41 | 8.69 | 9.29 | 356.20K |
| Sep 23, 2026 | 8.69 | 9.35 | 8.52 | 8.93 | 381.70K |
| Sep 22, 2026 | 8.34 | 9.04 | 8.28 | 8.77 | 491.90K |
| Sep 21, 2026 | 7.87 | 8.38 | 7.66 | 8.34 | 438.20K |
| Sep 18, 2026 | 7.39 | 7.91 | 7.24 | 7.79 | 501.70K |
About Alpha Teknova
Alpha Teknova (TKNO) is listed on the Nasdaq and classified by the SEC under “In Vitro & In Vivo Diagnostic Substances”. Its business address is in HOLLISTER, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1850902.
TKNO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Martha J Demski | Director | Jul 16, 2026 |
| Stephen Gunstream | President and CEO | Mar 9, 2026 |
| Brett Robertson | Director | Jun 2, 2026 |
| Alexander Vos | Director | Jun 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stephen Gunstream | President and CEO | Mar 9, 2026 |
| Matthew Lowell | Chief Financial Officer | Mar 9, 2026 |
| Damon Terrill | General Counsel and CCO | Mar 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 6, 2026 | Stephen Gunstream | Buy | 26,000 | $2.15 |
| Mar 6, 2026 | Matthew Lowell | Buy | 40,000 | $2.19 |
TKNO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $40.52M | $-17.26M | -0.32 | $-8.65M |
| Dec 31, 2024 | $37.74M | $-26.75M | -0.57 | $-12.39M |
| Dec 31, 2023 | $36.68M | $-36.78M | -1.16 | $-18.81M |
| Dec 31, 2022 | $41.42M | $-47.47M | -1.69 | $-27.40M |
| Dec 31, 2021 | $36.89M | $-9.80M | -0.61 | $-9.07M |
Latest balance sheet: total assets $95.88M, total liabilities $33.28M, cash $6.00M (as of Jun 30, 2026).
TKNO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $5.61 |
| May 6, 2026 | 8-K Item 2.02 (results) | $3.64 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $2.28 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $4.81 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $4.34 |
| May 8, 2025 | 8-K Item 2.02 (results) | $6.37 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $6.04 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $6.89 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| Jul 9, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 11, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Lantheus (LNTH)Intellia Therapeutics (NTLA)Neogen (NEOG)Celldex Therapeutics (CLDX)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Insight Molecular Diagnostics (IMDX)Volitionrx (VNRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on TKNO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.